However, because neurotrophic factors have been reported to play a potential role in cancer aggressiveness [3], we performed a systematic preclinical and clinical evaluation of the effect of GDNF in HNSCC through the use of several different cell lines and patient cohorts. This evidence concerns the gene GDNF and cancer.